Trump reverses Biden policies on drug pricing and Obamacare
As President Donald Trump’s health care agenda for a second term takes shape, it’s becoming clear that many Biden-era policies won’t make the cut.
As President Donald Trump’s health care agenda for a second term takes shape, it’s becoming clear that many Joe Biden-era policies won’t make the cut.
On Monday, Trump signed a sweeping order aimed in part at reversing several Biden administration executive orders on health care, including efforts to lower the cost of prescription drugs for people on Medicare and Medicaid, enhancing the Affordable Care Act and increasing protections for Medicaid enrollees. The so-called initial rescissions order, according to the Trump White House, is aimed at Biden policies that it says are “deeply unpopular” and “radical.”
The moves by Trump, experts say, are likely to be inconsequential to many Americans in terms of what they pay in out-of-pocket health care costs.
One Biden effort overturned by Trump, for example, had directed Medicare to look at ways to lower drug costs, including whether to impose a $2 monthly out-of-pocket cap on certain generic drugs.
That initiative, however, was only in the development stage, said Stacie Dusetzina, a health policy professor at Vanderbilt University in Nashville, Tennessee, and it was unclear whether it would be implemented at all.
Rating: 5